Robert Hromas, MD, has joined Samuel Waxman Cancer Research Foundation’s scientific advisory board.
Hromas will join other board members at the foundation’s scientific review and symposium in May. They will evaluate progress reports from the foundation’s funded researchers as part of the annual grant renewal process.
Robert Hromas, MD
“We are most pleased to welcome Rob Hromas to our scientific advisory board,” Samuel Waxman, MD, the foundation’s founder and CEO, said in a press release. “He has a multifaceted background in cancer research, patient care and academia that will be an asset to the [board’s] evaluation of our grantees’ work at the upcoming scientific review.”
Hromas — known for his expertise in leukemia, lymphoma and myeloma — is chair of medicine at University of Florida Health and vice president of University of Florida Physicians Clinical Practice Association. He previously served as chief of hematology/oncology at University of New Mexico, as well as deputy director of UNM Cancer Center.